Delivery Order SPE2DB24D9248-SPE2DB24FGRCP
Award Date
7/10/24
Potential Completion Date
7/31/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $6,432.21 for the supply of NEXPLANON 68 MG IMPLANTS. The award was made by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, which is a defense agency. The contract does not have a set-aside designation. It is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,858.76 for the supply of NEXPLANON 68 MG IMPLANTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,288.14. The contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $41,024.40 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, which has a ceiling value of up to $499,999,999, covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This specific delivery order is for NEXPLANON 68 MG IMPLANTS, with a period of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $7,146.90 for the provision of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order (SPE2DB22D9251|SPE2DB24FR1JW) valued at $5,717.52 for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The $17,357.75 firm fixed-price delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a wide range of pharmaceutical products, including branded and generic prescription...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $7,146.90, is a firm-fixed price delivery order with no set-aside designation. It was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $14,293.80 for the supply of Nexplanon 68 MG implants. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 9, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business. This award is part of a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $7,146.90 and a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...